Als Limited Stock Net Income

CPBLF Stock  USD 16.10  0.30  1.83%   
As of the 14th of February 2026, ALS shows the mean deviation of 1.35, and Risk Adjusted Performance of 0.161. ALS Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm ALS Limited standard deviation, as well as the relationship between the treynor ratio and skewness to decide if ALS Limited is priced favorably, providing market reflects its regular price of 16.1 per share. Given that ALS has total risk alpha of 0.377, we suggest you to validate ALS Limited's prevailing market performance to make sure the company can sustain itself in the future.
ALS's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ALS's valuation are provided below:
ALS Limited does not today have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
It's important to distinguish between ALS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ALS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, ALS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

ALS 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ALS's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ALS.
0.00
11/16/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/14/2026
0.00
If you would invest  0.00  in ALS on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding ALS Limited or generate 0.0% return on investment in ALS over 90 days. ALS is related to or competes with Fluidra SA, Yamato Holdings, SG Holdings, Arcadis NV, and InPost SA. ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in A... More

ALS Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ALS's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ALS Limited upside and downside potential and time the market with a certain degree of confidence.

ALS Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ALS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ALS's standard deviation. In reality, there are many statistical measures that can use ALS historical prices to predict the future ALS's volatility.
Hype
Prediction
LowEstimatedHigh
12.6316.1019.57
Details
Intrinsic
Valuation
LowRealHigh
14.2717.7421.21
Details

ALS February 14, 2026 Technical Indicators

ALS Limited Backtested Returns

ALS appears to be not too volatile, given 3 months investment horizon. ALS Limited secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2 % return per unit of risk over the last 3 months. By reviewing ALS's technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please makes use of ALS's mean deviation of 1.35, and Risk Adjusted Performance of 0.161 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ALS holds a performance score of 15. The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ALS's returns are expected to increase less than the market. However, during the bear market, the loss of holding ALS is expected to be smaller as well. Please check ALS's skewness, as well as the relationship between the day median price and period momentum indicator , to make a quick decision on whether ALS's price patterns will revert.

Auto-correlation

    
  0.45  

Average predictability

ALS Limited has average predictability. Overlapping area represents the amount of predictability between ALS time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ALS Limited price movement. The serial correlation of 0.45 indicates that just about 45.0% of current ALS price fluctuation can be explain by its past prices.
Correlation Coefficient0.45
Spearman Rank Test0.6
Residual Average0.0
Price Variance1.93
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, ALS Limited reported net income of 190.5 M. This is 26.57% lower than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The net income for all United States stocks is 66.64% higher than that of the company.

ALS Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ALS's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of ALS could also be used in its relative valuation, which is a method of valuing ALS by comparing valuation metrics of similar companies.
ALS is currently under evaluation in net income category among its peers.

ALS Fundamentals

About ALS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ALS Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ALS Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in ALS Pink Sheet

ALS financial ratios help investors to determine whether ALS Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALS with respect to the benefits of owning ALS security.